Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Preventing type 2 diabetes

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Type 2 diabetes is one of the few major chronic diseases where prevention has been tested directly in large randomised trials, and where it worked.

The interventions that worked are modest and specific, which is useful: the numbers below are not aspirations, they are what was actually tested.

Related pages: Type 2 diabetes

The bottom line

What we know
  • Structured lifestyle programs reduce progression from prediabetes to diabetes by about 58 percent over three years.
  • A 5 to 7 percent weight loss is the tested target.
  • 150 minutes a week of moderate activity is the tested dose.
  • Metformin reduces progression by about 31 percent, more in younger adults and those with higher body weight.
  • Screening from age 35 identifies the people for whom this matters.
What is still open
  • Whether preventing a diagnosis also prevents heart attacks and strokes, or only delays the label.
  • Whether newer weight-loss medicines prevent diabetes as durably.
  • How to deliver prevention programs at a scale that reaches those at highest risk.

The story, step by step

  1. 1. The evidence ()
  2. 2. Weight ()
  3. 3. Activity ()
  4. 4. Food ()
  5. 5. Sleep and the rest ()
  6. 6. Screening ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 6

What the trials showed

Review of many studies

What happens

A rare, clean result in prevention.

What the research shows

  • The Diabetes Prevention Program randomised over 3,000 United States adults with prediabetes to a structured lifestyle program, metformin or placebo.
  • The lifestyle group cut progression to diabetes by 58 percent over about three years; metformin cut it by 31 percent.
  • In adults over 60, the lifestyle effect reached around 71 percent. Metformin worked best in those under 45 and those with higher body weight.
  • Finnish and Chinese trials found comparable results, with the Chinese study showing reduced diabetes incidence persisting for decades.
  • Follow-up showed the benefit narrowing over time as control groups also progressed, but the delay in onset persisted.
  • The lifestyle arm was not a diet sheet. It was a year of structured sessions with a coach, which is what the CDC's National Diabetes Prevention Program reproduces.

Why it matters

Prevention here is evidence-based in the strict sense. The specific numbers people are told to hit are the ones that were tested and worked.

What's still uncertain

  • Whether the delay in diagnosis translates into fewer cardiovascular events.
  • How much of the effect requires the coaching rather than the information.

Read more

Next: Weight

Part 2 of 6

The 7 percent target

Review of many studies

What happens

Smaller than most people assume.

What the research shows

  • The trial target was 7 percent of starting body weight, achieved gradually.
  • For someone at 200 pounds that is 14 pounds; at 250 pounds, about 17.
  • Each kilogram lost in the trial was associated with a measurable reduction in diabetes risk, so partial success still counted.
  • Fat lost from the liver and abdomen improves insulin sensitivity disproportionately, which is why modest overall loss produces a large metabolic effect.
  • Maintenance is harder than loss, and the programs that worked included long-term support rather than a short intervention.
  • Weight-loss medicines reduce progression to diabetes substantially in trials, though the effect depends on continued treatment.

Why it matters

Setting the bar at 7 percent rather than at an ideal weight is what makes this achievable, and it is enough.

What's still uncertain

  • Durability of prevention from weight-loss medicines after stopping.
  • The best maintenance strategies beyond two years.

Read more

Next: Activity

Part 3 of 6

The 150 minutes

Review of many studies

What happens

And what to do with it.

What the research shows

  • The tested dose was 150 minutes a week of moderate activity, commonly brisk walking, spread across the week.
  • Activity reduces risk partly through weight and substantially independent of it, because working muscle disposes of glucose without insulin.
  • Resistance training two to three times weekly adds further benefit by building the tissue that does that disposal.
  • Breaking up prolonged sitting improves glucose handling independently of planned exercise.
  • The largest gains come from moving from nothing to something, not from adding to an already active routine.
  • Walking after meals blunts the post-meal glucose rise most effectively.

Why it matters

The dose is specific and modest, and it is the most reliably effective non-surgical intervention in this entire story.

What's still uncertain

  • Whether shorter high-intensity formats give equivalent prevention.
  • The independent contribution of reducing sedentary time.

Read more

Next: Food

Part 4 of 6

What the pattern looks like

Review of many studies

What happens

Fibre up, refined carbohydrate and sugary drinks down.

What the research shows

  • Replace refined grains with whole grains, legumes and vegetables. Fibre slows glucose absorption and improves insulin sensitivity.
  • Eliminate sugar-sweetened drinks. They are the fastest route to a glucose spike and carry no satiety.
  • Favour unsaturated fats, nuts, olive oil and fish; limit processed meat and trans fats.
  • Mediterranean-style patterns have the strongest evidence for reducing diabetes incidence among whole-diet approaches.
  • Portion size matters as much as composition. The trial diets were moderate in calories, not exotic.
  • Coffee, including decaffeinated, is consistently associated with lower diabetes risk in observational studies, though causation is unproven.

Why it matters

No prevention trial required an unusual diet. They required fewer calories, more fibre and far fewer sugary drinks.

What's still uncertain

  • Which dietary components carry the causal effect.
  • Whether the coffee association reflects causation.

Read more

Next: Sleep and the rest

Part 5 of 6

The overlooked contributors

Review of many studies

What happens

Short sleep and apnea raise risk measurably.

What the research shows

  • Chronic short sleep, under about six hours, is associated with insulin resistance and higher diabetes risk.
  • Obstructive sleep apnea is strongly associated with type 2 diabetes and is common and underdiagnosed, especially in people with abdominal weight, loud snoring or witnessed pauses in breathing.
  • Shift work disrupts circadian rhythms and is associated with higher risk.
  • Smoking increases the risk of developing type 2 diabetes, in addition to its cardiovascular effects.
  • Chronic stress raises cortisol, which opposes insulin and raises glucose.
  • Some medicines raise blood sugar, including corticosteroids, some antipsychotics and some HIV therapies. That does not mean stopping them, but it does mean monitoring.

Why it matters

Sleep is the part of prevention most often left out of the advice, despite having a measurable effect on insulin sensitivity within days.

What's still uncertain

  • Whether treating sleep apnea reduces diabetes incidence.
  • How much of the shift-work association is causal.

Read more

Next: Screening

Part 6 of 6

Knowing where you stand

Review of many studies

What happens

The step everything else depends on.

What the research shows

  • Screening is recommended for adults aged 35 to 70 who are overweight or obese, and repeated at least every three years if normal.
  • Earlier screening applies with a family history, a history of gestational diabetes, polycystic ovary syndrome, high blood pressure, abnormal lipids, or membership of higher-prevalence population groups.
  • An A1C or fasting glucose is enough to start, and A1C requires no fasting.
  • A result in the prediabetes range should lead to a referral to a structured prevention program, not just advice to lose weight.
  • The CDC's National Diabetes Prevention Program is delivered in person and online across the United States and is covered by many insurers.
  • Rescreen yearly after a prediabetes result.

Why it matters

Most people with prediabetes do not know they have it. A single cheap test moves them into the group where all of the above applies.

What's still uncertain

  • How to improve referral rates into prevention programs.
  • Whether screening below age 35 is now justified.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.